CAMICI, MARCELLO
 Distribuzione geografica
Continente #
NA - Nord America 8.188
AS - Asia 5.241
EU - Europa 4.465
SA - Sud America 397
AF - Africa 143
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.437
Nazione #
US - Stati Uniti d'America 7.896
CN - Cina 1.899
SG - Singapore 1.543
IT - Italia 1.279
PL - Polonia 795
HK - Hong Kong 786
SE - Svezia 590
KR - Corea 545
UA - Ucraina 441
BG - Bulgaria 356
BR - Brasile 349
CA - Canada 274
DE - Germania 238
FI - Finlandia 219
TR - Turchia 192
CH - Svizzera 185
VN - Vietnam 170
RU - Federazione Russa 148
GB - Regno Unito 117
CI - Costa d'Avorio 104
FR - Francia 41
AR - Argentina 19
BE - Belgio 18
IN - India 18
BD - Bangladesh 16
IQ - Iraq 16
MX - Messico 11
ZA - Sudafrica 10
JP - Giappone 9
PK - Pakistan 8
BJ - Benin 7
EC - Ecuador 7
MA - Marocco 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
VE - Venezuela 7
NL - Olanda 6
PY - Paraguay 6
AT - Austria 5
CZ - Repubblica Ceca 5
ES - Italia 4
IR - Iran 4
MY - Malesia 4
PE - Perù 4
RS - Serbia 4
CO - Colombia 3
DK - Danimarca 3
ET - Etiopia 3
ID - Indonesia 3
KE - Kenya 3
AU - Australia 2
CL - Cile 2
DZ - Algeria 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
KH - Cambogia 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
SN - Senegal 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 18.437
Città #
Ann Arbor 949
Singapore 869
Hong Kong 778
Woodbridge 775
Chandler 746
Ashburn 723
Hefei 715
Milan 617
Jacksonville 597
Seoul 545
Houston 535
Santa Clara 430
Sofia 354
Dallas 353
Fairfield 296
Ottawa 264
Beijing 259
New York 218
Shanghai 205
Bern 185
Nanjing 163
Seattle 146
Boardman 145
Lawrence 141
Princeton 141
Des Moines 133
Wilmington 113
Izmir 109
Jüchen 108
Abidjan 104
Cambridge 100
Medford 98
Dearborn 92
Los Angeles 88
Istanbul 76
Nanchang 65
Buffalo 58
Dong Ket 51
Kunming 42
Boulder 41
Rome 37
Tianjin 34
São Paulo 30
Redondo Beach 26
Shenyang 25
Munich 24
Changsha 20
Hebei 20
Ogden 19
Brussels 18
Verona 18
Council Bluffs 17
San Diego 17
Turku 17
Ho Chi Minh City 15
Norwalk 15
San Jose 14
Brasília 13
Jiaxing 11
London 11
Helsinki 10
Jinan 10
Pune 10
Serra 10
Belo Horizonte 9
Düsseldorf 9
Guangzhou 9
Hangzhou 9
Lanzhou 9
Rio de Janeiro 9
Curitiba 8
Orange 8
Tokyo 8
Washington 8
Changchun 7
Cotonou 7
Edinburgh 7
Falls Church 7
Redwood City 7
Salvador 7
Nürnberg 6
Paris 6
Tappahannock 6
Toronto 6
Atlanta 5
Baghdad 5
Brooklyn 5
Casablanca 5
Frankfurt am Main 5
Hanoi 5
Tashkent 5
Vienna 5
Amsterdam 4
Belgrade 4
Campinas 4
Cape Town 4
Chengdu 4
Chicago 4
Elk Grove Village 4
Falkenstein 4
Totale 13.092
Nome #
Renoprotective effect of renin-sngiotensin system block:what has happened? 900
Activation of coagulation during hemodialysis 223
Urinary detection of podocyte injury 195
Heparin and prostacyclin 194
Dialysis-associated bone disease 191
Urinary biomarkers of podocyte injury 189
Urinary excretion of oxalate in renal failure 188
Hemodialysis performed with RP610 and Gambro Lundia 181
The nephrotic syndrome is an immunoinflammatory disorder 179
Coagulation and colon cancer 178
Nephrotic proteinuria and the autonomic nervous system 176
Guanylin peptides and colorectal cancer (CRC) 174
Platelet count and betathromboglobulin in hemodialysis performed with prostacyclin and heparin 172
Unusual Takayasu's arteritis:case report 171
The role of the nervous system in the pathogenesis of nephrotic proteinuria 171
Vitamin D and heart 171
A method for in vivo platelet study inside artificial kidney 169
Il comportamento della curva di aggregazione piastrinica e disaggregazione in alcuni casi di maculopatia 167
Molecular pathogenetic mechanisms of nephrotic edema:progress in understanding 166
The effect of oxalic acid on human platelet rich plasma 165
Cardiac effects of prostacyclin infusion in healthy men 164
Lymphopressotherapy in chronic post-mastectomy lymphedema 163
Plasma exchange performed with prostaglandin I2 162
prostacyclin,heparin and membrane sieving coefficient in hemodialysis 158
Heparin and cell growth 158
Prostacyclin in hemodialysis 157
Platelets,prostacyclin and heparin during hemodialysis 156
Echocardiographic hemodinamic study during ultrafiltration sequential dialysis 155
Value of plasma exchange in the treatment of Bechet's disease 153
Obesity-related glomerulopathy and podocyte injury: a mini review 152
Plasma exchange performed with prostacyclin and ACD solution: comparative effects 151
Chronic renal failure:increased thrombin generation 151
Prostacyclin in hemodialisis 150
Renal Glomerular permselectivity and vascular endothelium 150
Duodenal plasmocytoma.A rare primary extramedullay localization simulating a carcinoma 148
Leucotrieni effeti biologici 147
Plasma exchange in bechet disease 145
Monitoring heparin therapy with the activated partial thromboplastin time 144
Manual lymphatic drainage for chronic post-mastectomy lymphoedema treatment 144
Aggregazione piastrinica in pazienti con insufficienza renale cronica non in dialisi 143
Heparin and prostacyclin in hemodialysis:lipidic pattern 143
Enhanced thrombin activity in chronic renal failure 143
Urinary oxalate output and lithiasis in chronic dialysis patients 142
Activated partial thromboplastin time resistance to heparin infusion in hemodialysis 142
prlonged plasma exchange (PE) in the treatment of renal involvement in essential mixed cryoglobulinemia(EMC) 141
Prostacyclin and heparin during hemodialysis 140
Tclopidine and thrombocyte function 137
the effect of oxalic acid on teh aggergability of human platelet rich plasma 136
Letter to editor 136
Heparin plasma level and activated partial thromboplastin time 136
Microcirculatory changes induced by pressure therapy in post-mastectomy lymphoedema of the arm 136
Microcirculation in chronic post-mastectomy 136
Extracorporeal hemodialysis,lipoprotein(a) and factor VII 135
Pilot study with subcutaneous (S.C.) low dose rIl-2 cyclically given in addition to 5-FU and leucovoruin in metastatic colorectal cancer 135
Studio ecocardiografico della funzione ventricolare sinistra in due diverse strategie dialitiche 133
Increased thrombin generation in patients with chronic renal failure 133
Peptide natriuretico cerebrale e insufficienza cardiaca 132
Thyroid hormones and the cardiovascular system: Pathophysiology and interventions 132
Manual lymphatic drainage for chronic post-mastectomy lymphoedema treatment 131
Solitary renal cyst.Sonografic diagnosis 131
Age related cardiovascular dysfunction anf effects of physical activity 131
tempo parziale di tromboplastina attivata e monitoraggio della terapia eparinica 130
Sequential dialysis:an echocardiographic and plasma variables study 129
Bleeding management in thrombocytopenic purpura; a case report 129
Abstract.Obesity related glomerulosclerosis(ORG)and podocyte injury 128
Podocyte dysfunction in aging related glomerulosclerosis:pathogenesis 128
safety and anticoagulation effect of administration of a low dose combination prostacyclin (PGI2) and low molecular weight heparin (LMWH) in hemodialysis.Preliminary evaluation 127
Abstract.The podocyte dysfunction in aging-related glomerulosclerosis:pathogenesis and possible interventions 127
Platelet function in non dialyzed patients in renal failure 126
Comportamento dell'amilasi nella insufficienza renale cronica 126
Obesity-related glomerulopathy and podocyte injury:a mini review with therapeutic perspective 126
safety and efficacy anticoagulation in extracorporeal hemodialysis by simultaneous administration of low dose prostacyclin and low molecular weight heparin 125
Usefulness of a rationale post-operative follow-up of breast cancer with tumors markers 125
Prostacyclin in hemodialysis 124
Prothrombin conversion into thrombin is accelerated in chronic uremia 123
Tissue factor pathway inhibitor 123
Monitoraggio della terapia eparinica 121
Manual lymphatic drainage for chronic post-mastectomy lymphoedema treatment 121
Diagnosis of uremic autonomic neuropathy 120
Valutazione mediante laser doppler delle modificazioni microcircolatorie indotte dalla pressoterapia nel linfedema post-mastectomia 119
Effetti cardiaci dell'infusione di prostaciclina 118
High plasma fibrinogen levels and reduced fibrinolytic activity in dogs intoxicayed with methylguanidine 118
Proteinuria e diabete:indagine epidemiologica 115
Il vomito 115
Segnali di membrana 114
safety with efficacy hemodialysis performance and anticoagulation by simultaneous administration of prostacyclin low dose and fractionated heparin low dose 114
Evidence of accelerated prthrombin conversion into thrombin in patients with chronic uremia 113
Successfull multiple dental extractions in an inhibitor hemophilic.A patiente treated with APCC(FEISA) 111
Ticlopidina e funzione piastrinica 110
C-reactive protein,atherosclerosis and cardiovascular disease.An update 109
Foosfolipase A2 associata alle lipoproteine 109
Thrombosis of internal jugular vein discovered by echo color doppler :a case report 109
Increased thrombin generation in patients with chronic renal failure 109
Attività antitrombotiche e protrombotiche dell'endotelio vascolare 108
Fattore attivante piastrinico e progressione del danno renale 108
Progressione della insufficienza renale e fattore attivante piastrinico(PAF) 107
Cancro prostatico e screening con test PSA 107
Kidney disease and early detection 107
Functional reserve and glomerular hyperfiltration 107
tempo parziale di tromboplastina attivata:valutazione dells ensibilità per la determinazione dell'attività coagulante del fattore VIII 106
Totale 14.823
Categoria #
all - tutte 44.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.280


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021526 0 0 0 0 0 0 111 74 46 89 39 167
2021/20221.226 4 122 15 124 255 162 13 57 56 22 29 367
2022/20231.710 199 138 68 192 218 317 21 142 296 5 103 11
2023/20242.519 380 228 287 124 245 207 33 58 14 811 25 107
2024/20253.771 13 152 11 177 357 231 212 218 413 507 660 820
2025/20262.788 378 848 603 258 248 446 7 0 0 0 0 0
Totale 18.481